Annual Drug Patent Expirations for VABOMERE
Vabomere is a drug marketed by Rempex and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
Drug patent litigation for VABOMERE.
This drug has forty-seven patent family members in twenty-seven countries.
The generic ingredient in VABOMERE is meropenem; vaborbactam. One supplier is listed for this compound. Additional details are available on the meropenem; vaborbactam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
